Market Price

3.42 

-0.02 -0.6%

as of Nov 16 '18

52 Week Range:

3.36 7.12


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment, debt collection and related, emergency medical, management, food and catering, procurement, and healthcare management services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. Mediclinic International plc was founded in 1983 and is based in Stellenbosch, South Africa.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Mar '12 Dec '12 Mar '13 Dec '13 Mar '14 Dec '14 Mar '15 Mar '16 Mar '17 Mar '18
Equity (BVPS) 3.07
5.27
5.22
growth rate 71.7% -1.0%
Earnings BIT 50.38
61.71
4,152.00
75.06
5,549.00
85.40
322.00
289.00
364.00
354.00
growth rate 10.7% 6,628.8% -98.2% 7,293.2% -98.5% 277.0% -10.3% 26.0% -2.8%
Avg.PE 27.96
25.94
65.33
growth rate -7.2% 151.9%
ROA 2.47
-1.76
4.77
5.69
3.21
3.28
-7.15
growth rate -100.0% 100.0% 9.2% -43.6% 2.2% -100.0%
ROE 11.78
-6.92
14.62
15.08
6.65
6.03
-13.35
growth rate -100.0% 100.0% 1.6% -55.9% -9.3% -100.0%
ROIC 6.48
-0.13
7.54
8.70
4.69
4.82
-8.16
growth rate -100.0% 100.0% 7.4% -46.1% 2.8% -100.0%
Cur. Ratio 1.40
1.46
1.36
1.68
1.20
1.81
1.83
growth rate 2.1% -3.5% 11.1% -28.6% 50.8% 1.1%
Quick Ratio 1.30
1.35
1.25
1.54
1.10
1.64
1.66
growth rate 1.9% -3.8% 11.0% -28.6% 49.1% 1.2%
Leverage 4.96
3.27
2.88
2.47
1.87
1.82
1.93
growth rate -18.8% -6.2% -7.4% -24.3% -2.7% 6.0%
Balance Sheet Dec '11 Mar '12 Dec '12 Mar '13 Dec '13 Mar '14 Dec '14 Mar '15 Mar '16 Mar '17 Mar '18
Acct.Receivable 71.28
73.42
5,471.00
70.95
6,801.00
98.90
417.00
549.00
593.00
608.00
growth rate 1.5% 7,351.7% -98.7% 9,485.1% -98.6% 321.6% 31.7% 8.0% 2.5%
Acct.Payable 37.94
49.41
4,121.00
64.77
5,048.00
70.19
157.00
200.00
227.00
210.00
growth rate 14.1% 8,239.9% -98.4% 7,693.3% -98.6% 123.7% 27.4% 13.5% -7.5%
Cur.Assets 151.91
159.26
8,857.00
211.29
11,226.00
233.12
742.00
931.00
1,069.00
961.00
growth rate 2.4% 5,461.5% -97.6% 5,213.2% -97.9% 218.3% 25.5% 14.8% -10.1%
Total Assets 174.72
180.56
56,742.00
260.59
70,534.00
328.15
4,396.00
6,549.00
7,422.00
6,343.00
growth rate 1.7% 31,325.4% -99.5% 26,966.8% -99.5% 1,239.6% 49.0% 13.3% -14.5%
Cash 61.32
55.66
2,705.00
107.68
3,521.00
82.88
265.00
305.00
361.00
261.00
growth rate -4.7% 4,760.0% -96.0% 3,169.9% -97.7% 219.7% 15.1% 18.4% -27.7%
Inventory 14.30
14.24
681.00
16.48
904.00
20.39
60.00
75.00
90.00
90.00
growth rate -0.2% 4,682.6% -97.6% 5,384.4% -97.8% 194.3% 25.0% 20.0% 0.0%
Cur.Liabilities 61.48
78.58
6,048.00
66.25
8,244.00
73.94
442.00
787.00
590.00
525.00
growth rate 13.1% 7,596.6% -98.9% 12,344.5% -99.1% 497.8% 78.1% -25.0% -11.0%
Liabilities 71.25
183.47
38,740.00
79.89
45,143.00
89.92
2,556.00
2,979.00
3,258.00
2,970.00
growth rate 60.5% 21,014.8% -99.8% 56,410.0% -99.8% 2,742.7% 16.6% 9.4% -8.8%
LT Debt 1.18
96.24
25,436.00
28,742.00
1,576.00
1,543.00
1,963.00
1,868.00
growth rate 802.7% 26,330.9% 6.3% -76.6% -2.1% 27.2% -4.8%
Equity 24,468.00
1,779.00
3,509.00
4,086.00
3,286.00
growth rate -73.0% 97.3% 16.4% -19.6%
Common Shares 708.45
704.00
763.00
711.63
830.00
711.63
550.00
599.00
737.00
737.00
growth rate -0.6% 4.1% -6.7% 16.6% -14.3% -22.7% 8.9% 23.0% 0.0%
Cash Flow Statement Dec '11 Mar '12 Dec '12 Mar '13 Dec '13 Mar '14 Dec '14 Mar '15 Mar '16 Mar '17 Mar '18
Capital Expenditures 8.18
6.73
2,022.00
12.28
2,605.00
26.84
177.00
177.00
232.00
254.00
growth rate -9.3% 29,944.6% -99.4% 21,113.4% -99.0% 559.5% 0.0% 31.1% 9.5%
Cash Dividends 688.00
47.00
48.00
62.00
58.00
growth rate -73.9% 2.1% 29.2% -6.5%
Cash From OA 56.92
52.24
3,549.00
86.26
4,615.00
79.41
337.00
320.00
377.00
345.00
growth rate -4.2% 6,693.1% -97.6% 5,249.9% -98.3% 324.4% -5.0% 17.8% -8.5%
FCF per Share 0.11
0.24
0.13
growth rate 118.2% -45.8%
Sale Purchase of Stock 7.00
177.00
1,091.00
growth rate 402.9% 516.4%
FCF 48.75
180.00
45.51
108.00
73.98
114.00
52.57
143.00
134.00
145.00
91.00
growth rate 269.3% -74.7% 137.3% -31.5% 54.1% -53.9% 172.0% -6.3% 8.2% -37.2%
Income Statement Dec '11 Mar '12 Dec '12 Mar '13 Dec '13 Mar '14 Dec '14 Mar '15 Mar '16 Mar '17 Mar '18
Sales 292.89
324.36
24,436.00
365.04
30,495.00
449.06
1,977.00
2,107.00
2,749.00
2,870.00
growth rate 5.2% 7,433.5% -98.5% 8,253.9% -98.5% 340.3% 6.6% 30.5% 4.4%
Op.Income 50.38
61.71
4,152.00
75.06
5,549.00
85.40
322.00
289.00
364.00
354.00
growth rate 10.7% 6,628.8% -98.2% 7,293.2% -98.5% 277.0% -10.3% 26.0% -2.8%
IBT 4,362.00
266.00
245.00
307.00
-479.00
growth rate -75.3% -7.9% 25.3% -100.0%
Net Income 50.84
60.48
-1,105.00
61.39
3,385.00
81.21
241.00
177.00
229.00
-492.00
growth rate 9.1% -100.0% 100.0% 5,413.8% -97.6% 196.8% -26.6% 29.4% -100.0%
EPS 0.14
-0.11
0.23
0.44
0.29
0.31
-0.67
growth rate -100.0% 100.0% 38.3% -34.1% 6.9% -100.0%
Gross Profit 117.71
135.67
10,555.00
154.54
13,306.00
192.01
793.00
843.00
1,053.00
1,097.00
growth rate 7.4% 7,679.9% -98.5% 8,510.2% -98.6% 313.0% 6.3% 24.9% 4.2%

Quarterly Statements

Item Name Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Earnings BIT 97.50
69.00
69.00
108.00
108.00
growth rate -29.2% 0.0% 56.5% 0.0%
Balance Sheet Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Acct.Receivable 593.00
546.00
546.00
608.00
608.00
growth rate -7.9% 0.0% 11.4% 0.0%
Acct.Payable 227.00
379.00
379.00
210.00
210.00
growth rate 67.0% 0.0% -44.6% 0.0%
Cur.Assets 1,069.00
899.00
899.00
961.00
961.00
growth rate -15.9% 0.0% 6.9% 0.0%
Total Assets 7,422.00
6,979.00
6,979.00
6,343.00
6,343.00
growth rate -6.0% 0.0% -9.1% 0.0%
Cash 361.00
262.00
262.00
261.00
261.00
growth rate -27.4% 0.0% -0.4% 0.0%
Inventory 90.00
87.00
87.00
90.00
90.00
growth rate -3.3% 0.0% 3.5% 0.0%
Cur.Liabilities 590.00
512.00
512.00
525.00
525.00
growth rate -13.2% 0.0% 2.5% 0.0%
Liabilities 3,258.00
3,057.00
3,057.00
2,970.00
2,970.00
growth rate -6.2% 0.0% -2.9% 0.0%
LT Debt 1,963.00
1,863.00
1,863.00
1,868.00
1,868.00
growth rate -5.1% 0.0% 0.3% 0.0%
Equity 4,086.00
3,849.00
3,849.00
3,286.00
3,286.00
growth rate -5.8% 0.0% -14.6% 0.0%
Common Shares 74.00
74.00
74.00
74.00
74.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Capital Expenditures 82.00
59.50
59.50
67.50
67.50
growth rate -27.4% 0.0% 13.5% 0.0%
Cash Dividends 8.50
17.50
17.50
11.50
11.50
growth rate 105.9% 0.0% -34.3% 0.0%
Cash From OA 118.50
74.50
74.50
98.00
98.00
growth rate -37.1% 0.0% 31.5% 0.0%
FCF 36.50
15.00
15.00
30.50
30.50
growth rate -58.9% 0.0% 103.3% 0.0%
Income Statement Mar '17 Jun '17 Sep '17 Dec '17 Mar '18
Sales 733.00
702.50
702.50
732.50
732.50
growth rate -4.2% 0.0% 4.3% 0.0%
Op.Income 97.50
69.00
69.00
108.00
108.00
growth rate -29.2% 0.0% 56.5% 0.0%
IBT 79.50
-5.00
-5.00
-234.50
-234.50
growth rate -100.0% 0.0% 0.0% 0.0%
Net Income 59.50
-25.00
-25.00
-221.00
-221.00
growth rate -100.0% 0.0% 0.0% 0.0%
Gross Profit 277.00
260.00
260.00
288.50
288.50
growth rate -6.1% 0.0% 11.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (14.40)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 0.00 -5.13 0.00
EPS / Growth -13.4% -0.67 7.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 19.3% 31.6%
Future PE 0.00 0.00 21.07
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.